Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | F10 | P00742 | 1/20 | 0.47 |
| ▸ | F7 | P08709 | 1/20 | 0.47 |
| ▸ | MTOR | P42345 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12366093 | 0.82 | MMP13 (0.52) | NPC1TP53LMNAHPGD | |
| SCHEMBL12366208 | 0.82 | SRC (0.57) | TP53 | |
| SCHEMBL24499495 | 0.81 | NPC1 (0.61) | NPC1MAPTALOX5F10F7 | |
| SCHEMBL6290205 | 0.81 | NPC1 (0.61) | NPC1MAPTALOX5F10F7 | |
| SCHEMBL6290206 | 0.81 | NPC1 (0.61) | NPC1MAPTALOX5F10F7 | |
| SCHEMBL12366096 | 0.81 | L3MBTL1 (0.57) | MAPTHPGDL3MBTL1 | |
| SCHEMBL11591975 | 0.80 | GAA (0.59) | MAPTLMNACYP2C19HPGDL3MBTL1 | |
| SCHEMBL17570500 | 0.80 | AOC3 (0.65) | NPC1MAPTALOX5F10F7 | |
| SCHEMBL4075832 | 0.80 | GAA (0.64) | NPC1MAPTALOX5MTORLMNA | |
| SCHEMBL30259901 | 0.80 | NPC1 (0.59) | NPC1MAPTALOX5F10F7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7998986-B2 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | EXELIXIS PATENT COMPANY LLC (US) | 2011-08-16 | — | — | US | disclosed |